Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOVASTATIN vs LOXOPROFEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOVASTATIN vs LOXOPROFEN: Safety Overview

Metric LOVASTATIN LOXOPROFEN
Total FAERS Reports 1,387 1,359
Deaths Reported 204 184
Death Rate 14.7% 13.5%
Hospitalizations 287 819
Average Patient Age 60.2 yrs 60.7 yrs
% Female Patients 55.9% 49.7%
FDA Approval Date Apr 14, 2006 N/A
Manufacturer Preferred Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A